Creative Financing Approaches in Life Science
By , , ,

This article is the third in a 4-part series reviewing financing solutions for the Life Science sector. As Life Science company valuations have fluctuated significantly over the last two years, and investors have become cautious due to economic turbulence and market uncertainty, fundraising is taking longer. Equity financing has been…Read More

Read More
How to Successfully Extend the Cash Runway to Growth in Early Commercial Stage Life Science Companies
By ,

This article is the second in a 4-part series reviewing financing solutions for the Life Science sector. Life Science venture capital and private equity-funded startups are constantly chasing capital to extend operating cash runways, driving value inflection milestones such as clinical trial data and funding growth for commercial-stage entities. Understandably,…Read More

Read More
Trends in Financing in Life Sciences: 2024 Updates
By

This article is first in a 4-part series reviewing financing solutions for the Life Science sector. As we move into Q2 of 2024, the Fed continues to hold the line on interest rate declines. Capital markets remain tight and for companies in need of growth financing, this is problematic. This…Read More

Read More
Planning a Medical Device Business is Not for the Faint of Heart
By

Creating a business plan for a medical device company is a complex challenge, even for the most experienced founder and management team. A medical device business must contend with many of the same issues that face other technology-driven businesses. These include difficult engineering challenges, fundamental physical or biological constraints, complex…Read More

Read More

More Posts